A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia

Published:2000-03 Issue:3 Volume:24 Page:183-187
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Rosen Peter J.,Rankin Cathryn,Head David R.,Boldt David H.,Luthardt Frederick W.,Norwood Thomas,Pugh Reginald P.,Karanes Chatchada,Appelbaum Frederick R.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference17 articles.

1. Acute lymphoblastic leukemia in adults: recent progress, future directions;Hoelzer;Seminars. Hematol.,1987

2. A new regimen of amsacrine with high-dose cytarabine is safe and effective therapy for acute leukemia;Arlin;J. Clin. Oncol.,1987

3. Amsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adults;Arlin;Blood,1988

4. Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia;Arlin;Leukemia,1991

5. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia;Cheson;J. Clin. Oncol.,1990

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Drug-Disease Associations Using a Random Walk with Restart Method and Supervised Learning;Computational and Mathematical Methods in Medicine;2022-10-10

2. Re-induction chemotherapy using FLAG–mitoxantrone for adult patients with relapsed acute leukemia: a single-center experience from United Arab Emirates;International Journal of Hematology;2018-06-27

3. Chimeric Antigen Receptor Therapy in Acute Lymphoblastic Leukemia Clinical Practice;Current Hematologic Malignancy Reports;2017-06-27

4. The Approach to Acute Lymphoblastic Leukemia in Older Patients: Conventional Treatments and Emerging Therapies;Current Hematologic Malignancy Reports;2016-03-03

5. How I treat adults with relapsed or refractory Philadelphia chromosome–negative acute lymphoblastic leukemia;Blood;2015-07-30